SOUTH SAN FRANCISCO, CA, Mammoth Biosciences announced an oversubscribed round of $45 million in its Series B, led by Decheng Capital.
Mammoth Biosciences Raises $45M in Series B
SOUTH SAN FRANCISCO, CA, Mammoth Biosciences announced an oversubscribed round of $45 million in its Series B, led by Decheng Capital.
